Cargando…
Mutagenic and Genotoxic Effect of Hydroxyurea
The hydroxyurea, a cytotoxic drug, is the mainly available therapeutical strategy for the treatment of sickle cell disease. This study aimed to evaluate the mutagenic and genotoxic potential of the hydroxyurea through the Salmonella/Microsome assay and micronucleus test in peripheral blood of mice....
Autores principales: | Santos, Jean L., Bosquesi, Priscila L., Almeida, Adélia E., Chin, Chung Man, Varanda, Eliana A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Master Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614842/ https://www.ncbi.nlm.nih.gov/pubmed/23675245 |
Ejemplares similares
-
Assessment of the In Vivo Genotoxicity of New Lead Compounds to Treat Sickle Cell Disease
por: dos Santos, Jean Leandro, et al.
Publicado: (2011) -
Mutagenicity of New Lead Compounds to Treat Sickle Cell Disease Symptoms in a Salmonella/Microsome Assay
por: dos Santos, Jean Leandro, et al.
Publicado: (2010) -
Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX/ERCC1 gene expression
por: Fogaça, Manoela Viar, et al.
Publicado: (2017) -
Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
por: de Oliveira, Emanuel Almeida Moreira, et al.
Publicado: (2019) -
Mutagenicity and genotoxicity of ClearTaste
por: Soni, B.K., et al.
Publicado: (2018)